论文部分内容阅读
用血府逐瘀汤加味治疗冠心病痰热血瘀证与痰浊血瘀证。红细胞膜流动性前者（０．２３７±０．０２１）明显高于同年龄健康对照组（０．２６７±０．０２５）．后者（０．２８７±０．０２１）明显低于对照组。治疗后两组患者的红细胞膜流动性均恢复至正常水平。动物实验血府逐瘀汤加清热化痰药与血府逐瘀汤加健脾化痰药均对正常小白鼠红细胞膜流动性无明显影响。说明血府逐瘀汤配伍不同祛痰药对冠心病血瘀证患者的红细胞膜流动性具有双向调整作用。
Use Xuefu Zhuyu Decoction to treat coronary heart disease, blood stasis syndrome and blood stasis syndrome. The erythrocyte membrane fluidity of the former (0.237 ± 0.021) was significantly higher than the same age healthy control group (0.267 ± 0.025). The latter (0.287±0.021) was significantly lower than the control group. After treatment, the red cell membrane fluidity of both groups returned to normal levels. Animal experiments Xuefu Zhuyu decoction and heat-clearing phlegm medicine and Xuefu Zhuyu decoction and invigorating spleen and phlegm-removing medicine have no obvious effect on the erythrocyte membrane fluidity of normal mice. It was demonstrated that the compatibility of Xuefu Zhuyu decoction with different peony drugs has a two-way adjustment effect on the red blood cell membrane fluidity in patients with coronary heart disease and blood stasis syndrome.